Matthew Kaplan Net Worth & Insider Trades
Matthew Kaplan - Director, Nuvectis Pharma, Inc
What is Matthew Kaplan's Net Worth?
The current estimated net worth of Nuvectis Pharma, Inc's Director, Matthew Kaplan, is estimated to be about $369.76K . Matthew Kaplan owns about 35,760 units of Nuvectis Pharma, Inc common stock. In the last month at Nuvectis Pharma, Inc, Matthew Kaplan has sold an estimated value of $0 worth.
What is Matthew Kaplan's Past Insider Trading?
Matthew Kaplan's largest purchase order was 3,000 units , worth over $50.63K on May 16, 2022. In total, Matthew Kaplan has made about 2 transactions over a month of their time at Nuvectis Pharma, Inc. Matthew Kaplan usually trades in May and April, with the busiest year in 2022.
Matthew Kaplan
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Matthew Kaplan's' Mailing Address?
- Mailing address is C/o Nuvectis Pharma, Inc. 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 NJ
What are Nuvectis Pharma, Inc's Past Insider Trades?
Nuvectis Pharma, Inc's most recent insider trade came on June 1, 2023 by Ron Bentsur who bought 330 units worth $5.7K . In the last year, insiders at Nuvectis Pharma, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in May, with the busiest year in 2022. The most active traders at the company are Ron Bentsur, Chairman & CEO, Shay Shemesh, Chief Dev. & Ops. Officer, and Enrique Poradosu, Chief Science & Business Off .
Nuvectis Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||